MRNA Stock Jumps on Global Submissions Seeking Nod for Flu Vaccine

Key Takeaways Moderna filed for approval of its seasonal flu vaccine mRNA-1010 in the US, EU, Canada and Australia.MRNA said late-stage data show mRNA-1010 immune responses match standard and high-dose flu shots.The filings could also support a potential future resubmission of its COVID-flu combo vaccine.Moderna (MRNA) announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 across the United States, European Union, Canada and Australia.These filings seek ...